Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo ...

Investing.com -- Novo Nordisk (NYSE: NVO) shares climbed 5.4% Friday after the U.S. Food and Drug Administration accepted the ...

Investing.com -- Novo Nordisk (NYSE: NVO) shares climbed 5.4% Friday after the U.S. Food and Drug Administration accepted the ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Here are Investing.com’s stocks of the week. Microsoft was one of many tech giants that reported earnings this week, with the company topping profit and revenue expectations. MSFT shares jumped more ...

The U.S. stock market continued to rebound from a period of volatility for the second straight week, with the S&P 500 closing ...

Viruses are known to use the genetic machinery of the human cells they invade to make copies of themselves. As part of the process, viruses leave behind remnants throughout the genetic material ...

SETWorks, a leading software provider for disability service agencies and human services providers, has secured a strategic growth investment from Polaris Growth Fund ...

A decision is expected in the fourth quarter of 2025.

NEW YORK CITY, NY / ACCESS Newswire / May 2, 2025 / In an era where healthcare is as much about timely access and ...

Seasonique (0.15 mg levonorgestrel and 0.03 mg ethinyl estradiol pills, 0.01 mg and ethinyl estradiol pills) (DIN 02346176) ...